TOLEROGENICS
Changing the game. Tolerogenics S.à.r.l. has developed several key technologies to overcome today’s bottlenecks in immunotherapy treatment. Tolerogenic’s has used these technologies to create a novel patent-protected approach of tolerance induction to achieve long-term cure of allergy diseases. The experienced management of Tolerogenics will provide the strategic and regulatory support to bring the products to market.
TOLEROGENICS
Industry:
Biopharma Biotechnology Life Science Medical
Founded:
2016-07-01
Address:
Esch-sur-alzette, Luxembourg, Luxembourg
Country:
Luxembourg
Website Url:
http://www.tolerogenics.lu
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Apache Wordpress Plugins
Similar Organizations
CN Bio Innovations
CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Official Site Inspections
http://www.tolerogenics.lu
- Host name: dd20830.kasserver.com
- IP address: 85.13.140.226
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "ToleroGenics"
Company - Tolerogenics S.a.r.l.
Tolerogenics S.à.r.l. is a private-public-partnership venture with the Luxembourg Institute of Health (LIH), a center of scientific excellence in the field of immunology. The company was …See details»
ToleroGenics - Crunchbase Company Profile & Funding
Tolerogenics S.à.r.l. has developed several key technologies to overcome today’s bottlenecks in immunotherapy treatment. Tolerogenic’s has used these technologies to create a novel patent …See details»
Tolerogenics - Company Profile - Tracxn
Tolerogenics - Developing novel tolerance-inducing immunotherapy treatments for allergy and autoimmune diseases. Founded by Leo W Tristram and Markus W Ollert in the year 2016. ...See details»
Tolerogenics Sàrl - Research, Development Esch-sur-Alzette - Editus
Tolerogenics Sàrl Research, Development 29 Rue Henri Koch L-4354 Esch-sur-Alzette (Esch-Uelzecht) See the number 20 88 01 65 Getting ThereSee details»
Technology - Tolerogenics S.a.r.l.
One of Tolerogenics patent-protected enabling technologies to achieve the induction of tolerance is the thermosensitive ImmuneGel technology. The proprietary hydrogel composition can be …See details»
Tolerogenics SARL - datocapital.lu
Document Type Publication date Download link; Financials: Jul 5, 2022: Filing of financial statement Jan 1 2021 - Dec 31 2021: Financials: Aug 31, 2021: Filing of financial statement …See details»
ToleroGenics – COBIOE
Directory Through Value Chain Role of stakeholders in the value chain. Interactive map Explore geolocated information. News & Events Open menuSee details»
[LIH news] The... - Luxembourg Institute of Health - Facebook
Sep 19, 2019 [LIH news] The Luxembourg-based biotech start-up Tolerogenics is developing novel immunotherapies based on the induction of immune tolerance. LIH and Tolerogenics …See details»
Product pipeline - Tolerogenics S.a.r.l.
Based on the patent-protected technologies Tolerogenics S.à.r.l. has designed a pipeline of products for development. The technologies can be employed to enhance existing …See details»
Luxembourg sets the pace in biotech | Paperjam English News
Sep 27, 2019 LIH teams up with Tolerogenics. As the surge in autoimmune disease is imminent, the Luxembourg Institute of Health has entered the biotech field. Its department of infection …See details»
ToleroGenics Reviews | Read Client Reviews of ToleroGenics.
Read reviews of ToleroGenics. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Search. …See details»
ToleroGenics - Craft
Tolerogenics is a company that engages in the discovery of the treatment of allergy and autoimmune diseases. It develops allergy immunotherapies against hymenoptera insect …See details»
LIH and Tolerogenics collaborate on immune tolerance-promoting ...
The Luxembourg-based biotech start-up Tolerogenics is developing novel immunotherapies based on the induction of immune tolerance. LIH and Tolerogenics have recently concluded a …See details»
https://tolerogenics.lu/home/technology/hydrogel... - Chemtrails ...
Oct 28, 2024 https://tolerogenics.lu/home/technology/hydrogel-technology/See details»
Patents & Intellectual Property - Tolerogenics S.a.r.l.
Tolerogenics holds several patents and patent applications in the field of immuotherapies based on tolerance induction. The patents provide freedom-to-operate in the development of novel …See details»
Tolerogenics SARL - Company Information, Competitors, News
Find useful insights on Tolerogenics SARL's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Tolerogenics SARL.See details»
Hydrogel technology - Tolerogenics S.a.r.l.
For the therapeutic approach of Tolerogenics, a sustained release for a time period of 2-3 days is important since the development of immunologic memory requires the engagement of a T cell …See details»
Tolerogenics - 82 Competitors and alternatives in Oct 2024 - Tracxn
Oct 28, 2024 Tolerogenics's competitors have raised a total of $1.15B funding across 100 funding rounds. See the distribution of funded competitors of Tolerogenics below. $0 $35M …See details»
PLGA nanoparticles - Tolerogenics S.a.r.l.
Tolerogenics offers the use of plain anionic PLGA nanospheres (size 300-500 nm) as a tolerance-promoting adjuvant in combination with established allergen-specific immunotherapy …See details»